SCHEMBL6501465

SCHEMBL6501465

CCOc1cnc(COS(C)(=O)=O)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
POLB P06746 2/20 0.38
LMNA P02545 1/20 0.38
SCN9A Q15858 3/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 3/20 0.33
TP53 P04637 2/20 0.33
NPC1 O15118 1/20 0.33
XBP1 P17861 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TLR9 Q9NR96 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32
CA12 O43570 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6487877 0.86 NPC1 (0.39) NPC1HSD17B10SMN1; SMN2
SCHEMBL6490655 0.81 L3MBTL1 (0.40) ALDH1A1POLBLMNASCN9ATDP1
SCHEMBL12415416 0.80 TRPM8 (0.34) ALDH1A1SCN9ATDP1L3MBTL1MAPT
SCHEMBL16728654 0.79 PLAU (0.34) ALDH1A1POLBSCN9ATDP1L3MBTL1
SCHEMBL21736838 0.77 NQO1 (0.38) ALDH1A1POLBLMNATDP1L3MBTL1
SCHEMBL6831543 0.77 LMNA (0.38) ALDH1A1POLBLMNAMAPTHTT
SCHEMBL1722950 0.75 L3MBTL1 (0.58) ALDH1A1POLBLMNATDP1L3MBTL1
SCHEMBL15918740 0.70 ALDH1A1 (0.50) ALDH1A1POLBLMNANPSR1KMT2A
SCHEMBL22493674 0.70 PLAU (0.34) LMNAL3MBTL1PTGS2
SCHEMBL6831545 0.70 LMNA (0.39) ALDH1A1POLBLMNASCN9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD ALDH1A1 96/4885POLB 3384/4885LMNA 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.